Benzinga Rankings give you vital metrics on any stock – anytime.
Explore MiNK Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INKT.
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Connect Biopharma Hldgs (NASDAQ:CNTB), Intensity Therapeutics (NASDAQ:INTS) and Burning Rock Biotech (NASDAQ:BNR).
MiNK Therapeutics has a consensus price target of $14.00.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $8.15 last updated April 7, 2025 at 8:01 AM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.